Drugs / BCG strain Danish
BCG strain Danish
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00396370 | Dec 2008 → Jul 2012 | tuberculosis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG strain Danish | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00396370 ↗ |
| Known as | Bacillus Calmette-Guerin | “Bacillus Calmette-Guerin (BCG) strain Danish from the Statens Serum Institute (SSI BCG). 1.2 X 10\^8 colony-forming units (CFU) oral (PO) in 60 mililiters phosphate buffered...” NCT00396370 ↗ |
| Known as | BCG | “Bacillus Calmette-Guerin (BCG) strain Danish from the Statens Serum Institute (SSI BCG). 1.2 X 10\^8 colony-forming units (CFU) oral (PO) in 60 mililiters phosphate buffered...” NCT00396370 ↗ |
| Known as | SSI BCG | “Bacillus Calmette-Guerin (BCG) strain Danish from the Statens Serum Institute (SSI BCG). 1.2 X 10\^8 colony-forming units (CFU) oral (PO) in 60 mililiters phosphate buffered...” NCT00396370 ↗ |
| Modality | Vaccine | “BCG” NCT00396370 ↗ |
| Route | Oral | “oral (PO)” NCT00396370 ↗ |